Status: current, Not sufficiently defined by necessary conditions definition status. Date: 05-Mar 2014. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 78540801000001116 | Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet (product) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 78540901000001110 | Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has dispensed dose form | Powder | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Is a | Virtual medicinal product pack | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has VMP | Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | VMP prescribing status (attribute) | VMP valid as a prescribable product | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | VMP non-availability indicator | Available | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has specific active ingredient | Sodium chloride | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has specific active ingredient | Sodium citrate | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has specific active ingredient | Glucose anhydrous | true | Inferred relationship | Existential restriction modifier | ||
| Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Has dispensed dose form | Drug powder | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Oral Rehydration Salts potassium free - Queens Hospital Burton formula powder sachets (Special Order) 30 sachet | Is a | True | Glucose anhydrous 20g / Sodium chloride 3.5g / Sodium citrate 2.9g oral powder sachets 30 sachet | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR